BACKGROUND AND PURPOSE: The WASID study established the risk of subsequent
ischemic stroke at 1 year in subjects with symptomatic intracranial atherosclerotic stenosis …

BACKGROUND AND PURPOSE: Intracranial angioplasty and stent placement are used to
treat intracranial atherosclerotic disease. The 2 interventions have not been directly …

Background The future of neuroendovascular treatment for intracranial atherosclerotic
disease (ICAD) has been debated since the results of SAMMPRIS reflected poor outcomes …

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in
Intracranial Stenosis trial1 (SAMMPRIS, ClinicalTrials. gov number, NCT00576693), as …

Background and Purpose—Intracranial angioplasty and stenting are therapeutic options for
patients with symptomatic intracranial arterial stenoses intractable to medical therapy …

Background and purpose In-stent restenosis (ISR) is one of the long-term adverse outcomes
of endovascular angioplasty and stenting for symptomatic intracranial arterial stenosis. In …

The management of intracranial atherosclerotic disease (ICAD) has been evolving with
advanced imaging, refinements of best medical treatment, and the development of …

Background Intracranial atherosclerotic disease (ICAD) is a common cause for stroke and
can be defined as symptomatic (stroke) or asymptomatic. Current guidelines recommend …

Medical treatment and endovascular therapy are widely used for intracranial atherosclerotic
stenosis, but the best treatment strategy remains uncertain. The goal of this study was to …

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and
Intracranial Stenosis (SAMMPRIS) trial, a randomized clinical trial comparing aggressive …